Barcelona, Spain
November 18 – Preclinical Poster Presentations
- MICVO mechanism of action (PB-054)
- MICVO in combination with EGFR-targeted therapy (PB-079)
November 19 – Late-Breaking Oral Presentation
- MICVO monotherapy in previously treated R/M HNSCC (Abstract 3LBA)
